Replies to post #3598 on Adhera Therapeutics Inc (ATRX)

[EOT]

MAJOR developments have already happened! How are they going to move forward with their Parkinson’s drug++??
So they have to make an announcement soon….

[EOT]

This guy has made many big pharma $bil’s.
Now he has his own baby…..ATRX.
I posted his plans before so let’s see what he does with his own stock…



Zahed Subhan
Chairman, CEO

CAREER HIGHLIGHTS

“I have over 30 years’ experience in the multinational pharmaceutical and biotechnology industries spanning senior roles in Research and Development, Marketing, Sales and Strategic Planning, including managerial positions with Sanofi-Aventis, GlaxoSmithKline, DuPont-Merck Pharmaceuticals, Gemini Genomics Inc. and Locus Pharmaceuticals Inc. Key positions held include: Head of Marketing and Sales, Vice President, Marketing and Business Development, and Chief Business Officer. I was also previously CEO of Nuevolution A/S based in Copenhagen, Denmark (acquired by Amgen) and CEO of Marillion Pharmaceuticals Inc. Presently I serve as Executive Chairman of Eppin Pharma Inc and CEO of Aestas Pharma Inc, both emerging biopharmaceutical companies. I have also raised over $50MM from venture capital firms to fund biotechnology enterprises, and have been instrumental in establishing more than 40 collaborations and co-operative agreements with major pharmaceutical and biotech companies, including licensing, co-marketing and acquisition transactions valued in excess of $600MM. Other career highlights include the successful launches of "blockbuster" drugs, including Imitrex®, Celexa®, Prinivil®/Zestril®, Sinemet CR® and Viazem®/Tiazac®, and the successful $100 MM IPO of Gemini Genomics Inc. and it's subsequent $220MM sale to Sequenom Inc.“